Cure My Disease

Don't miss your cure!

 Log in / Sign up

Ancient herb moutan cortex may soothe chemo nerve damage

NCT ID NCT07693374

Terminated Symptom relief Sponsor: Taiwan Municipal An-Nan Hospital-China Medical University Source: ClinicalTrials.gov ↗

First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This study tests whether Moutan Cortex, a Chinese herb containing paeonol, can relieve nerve pain and numbness caused by chemotherapy in breast cancer patients. Participants take the herb or a placebo daily for four weeks. Researchers measure pain levels and nerve function to see if the herb helps protect nerves and improve quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Moutan Cortex (herbal extract)
What this could lead to
If it works, this could offer a natural option to reduce nerve pain from chemotherapy, improving daily life for breast cancer survivors.
What could go wrong
This is a small, early-stage trial with no phase designation, so results may not be conclusive. The herb may not outperform a placebo, and side effects are not yet well understood.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm chemotherapy-induced neuropathy neuralgia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY (CIPN)

Contacts and locations

Locations

  • An Nan Hospital, China Medical University

    Tainan, Taiwan, 709, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.